1-16 of 16
Tian-Li Wang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract B002: ARID1A loss activates MAPK signaling via DUSP4 downregulation: a mechanistic insight in endometrial carcinoma

Jayaprakash Mandal, Zheng-Cheng Yu, Ie-Ming Shih, Tian-Li Wang
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (5_Supplement): B002.
https://doi.org/10.1158/1557-3265.ENDO24-B002
Published: 01 March 2024
View article titled, Abstract B002: ARID1A loss activates MAPK signaling via DUSP4 downregulation: a mechanistic insight in endometrial carcinoma
Journal Articles

Aneuploidy Landscape in Precursors of Ovarian Cancer

Yeh Wang, Christopher Douville, Yen-Wei Chien, Brant G. Wang, Chi-Long Chen, Andre Pinto, Saron Ann Smith, Ronny Drapkin, M. Herman Chui, Tricia Numan, Russell Vang, Nickolas Papadopoulos, Tian-Li Wang, Ie-Ming Shih
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (3): 600–615.
https://doi.org/10.1158/1078-0432.CCR-23-0932
Published: 01 February 2024
View article titled, Aneuploidy Landscape in Precursors of Ovarian Cancer
Open the PDF for Aneuploidy Landscape in Precursors of Ovarian Cancer in another window
Includes: Supplementary data
Journal Articles

Methylomic Landscapes of Ovarian Cancer Precursor Lesions

Thomas R. Pisanic, II, Yeh Wang, Hanru Sun, Michael Considine, Lihong Li, Tza-Huei Wang, Tian-Li Wang, Ie-Ming Shih
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (23): 6310–6320.
https://doi.org/10.1158/1078-0432.CCR-20-0270
Published: 01 December 2020
View article titled, Methylomic Landscapes of Ovarian Cancer Precursor Lesions
Open the PDF for Methylomic Landscapes of Ovarian Cancer Precursor Lesions in another window
Includes: Supplementary data
Journal Articles

Abstract PR11: Dual blockade of BRD4 and the ATR/WEE1 pathway exploits ARID1A loss in clear-cell ovarian cancers

Yasuto Kinose, Hyoung Kim, Haineng Xu, Sergey Medvedev, Erin George, Sarah Gitto, Margaret Whicker, Dorothy Hallberg, Lauren Schwartz, Gordon Mills, Victor E. Velculescu, Tian-Li Wang, Ronny Drapkin, Fiona Simpkins
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (13_Supplement): PR11.
https://doi.org/10.1158/1557-3265.OVCA19-PR11
Published: 01 July 2020
View article titled, Abstract PR11: Dual blockade of BRD4 and the ATR/WEE1 pathway exploits ARID1A loss in clear-cell ovarian cancers
Journal Articles

Loss of ARID1A in Tumor Cells Renders Selective Vulnerability to Combined Ionizing Radiation and PARP Inhibitor Therapy

Youngran Park, M. Herman Chui, Yohan Suryo Rahmanto, Zheng-Cheng Yu, Raghavendra A. Shamanna, Marina A. Bellani, Stephanie Gaillard, Ayse Ayhan, Akila Viswanathan, Michael M. Seidman, Sonia Franco, Anthony K.L. Leung, Vilhelm A. Bohr, Ie-Ming Shih, Tian-Li Wang
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (18): 5584–5594.
https://doi.org/10.1158/1078-0432.CCR-18-4222
Published: 13 September 2019
View article titled, Loss of ARID1A in Tumor Cells Renders Selective Vulnerability to Combined Ionizing Radiation and PARP Inhibitor Therapy
Open the PDF for Loss of ARID1A in Tumor Cells Renders Selective Vulnerability to Combined Ionizing Radiation and PARP Inhibitor Therapy in another window
Includes: Supplementary data
Journal Articles

Methylomic Analysis of Ovarian Cancers Identifies Tumor-Specific Alterations Readily Detectable in Early Precursor Lesions

Thomas R. Pisanic, II, Leslie M. Cope, Shiou-Fu Lin, Ting-Tai Yen, Pornpat Athamanolap, Ryoichi Asaka, Kentaro Nakayama, Amanda N. Fader, Tza-Huei Wang, Ie-Ming Shih, Tian-Li Wang
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (24): 6536–6547.
https://doi.org/10.1158/1078-0432.CCR-18-1199
Published: 13 December 2018
View article titled, Methylomic Analysis of Ovarian Cancers Identifies Tumor-Specific Alterations Readily Detectable in Early Precursor Lesions
Open the PDF for Methylomic Analysis of Ovarian Cancers Identifies Tumor-Specific Alterations Readily Detectable in Early Precursor Lesions in another window
Includes: Supplementary data
Journal Articles

Abstract A80: NAC1 attenuates BCL6 negative autoregulation and functions as a BCL6 coactivator of FOXQ1 transcription in ovarian cancer (OVCA).

Alice Laschuk Herlinger, Min Gao, Ren-Chin Wu, Tian-Li Wang, Leticia B A Rangel, Ie-Ming Shih
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (2_Supplement): A80.
https://doi.org/10.1158/1557-3265.OVCA15-A80
Published: 15 January 2016
View article titled, Abstract A80: NAC1 attenuates BCL6 negative autoregulation and functions as a BCL6 coactivator of FOXQ1 transcription in ovarian cancer (OVCA).
Journal Articles

Abstract A32: PBX1, a transcriptional regulator, promotes stemness and chemoresistance in ovarian cancer.

Jin-Gyoung Jung, Tae-Hoen Kim, Emily Gerry, Jen-Chun Kuan, Ayse Ayhan, Ben Davidson, Ie-Ming Shih, Tian-Li Wang
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (2_Supplement): A32.
https://doi.org/10.1158/1557-3265.OVCA15-A32
Published: 15 January 2016
View article titled, Abstract A32: PBX1, a transcriptional regulator, promotes stemness and chemoresistance in ovarian cancer.
Journal Articles

Mevalonate Pathway Antagonist Suppresses Formation of Serous Tubal Intraepithelial Carcinoma and Ovarian Carcinoma in Mouse Models

Yusuke Kobayashi, Hiroyasu Kashima, Ren-Chin Wu, Jin-Gyoung Jung, Jen-Chun Kuan, Jinghua Gu, Jianhua Xuan, Lori Sokoll, Kala Visvanathan, Ie-Ming Shih, Tian-Li Wang
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (20): 4652–4662.
https://doi.org/10.1158/1078-0432.CCR-14-3368
Published: 14 October 2015
View article titled, Mevalonate Pathway Antagonist Suppresses Formation of Serous Tubal Intraepithelial Carcinoma and Ovarian Carcinoma in Mouse Models
Open the PDF for Mevalonate Pathway Antagonist Suppresses Formation of Serous Tubal Intraepithelial Carcinoma and Ovarian Carcinoma in Mouse Models in another window
Includes: Supplementary data
Journal Articles

Abstract B15: Targeting PBX1 signaling to sensitize carboplatin cytotoxicity in ovarian cancer

Jin G. Jung, Joon T. Park, Alexader Stoeck, Tasmeen Hussain, Ren-Chin Wu, Ie-Ming Shih, Tian-Li Wang
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (4_Supplement): B15.
https://doi.org/10.1158/1557-3265.PMS14-B15
Published: 13 February 2015
View article titled, Abstract B15: Targeting PBX1 signaling to sensitize carboplatin cytotoxicity in ovarian cancer
Journal Articles

A novel quantum dot based nanoassay for high resolution copy number variation detection and DNA methylation quantification

Yi Zhang, Ie-Ming Shih, Tian-Li Wang, Tza-Huei Wang
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (19_Supplement): A17.
https://doi.org/10.1158/DIAG-10-A17
Published: 15 August 2014
View article titled, A novel quantum dot based nanoassay for high resolution copy number variation detection and DNA methylation quantification
Journal Articles

DNA Copy Numbers Profiles in Affinity-Purified Ovarian Clear Cell Carcinoma

Kuan-Ting Kuo, Tsui-Lien Mao, Xu Chen, Yuanjian Feng, Kentaro Nakayama, Yue Wang, Ruth Glas, M. Joe Ma, Robert J. Kurman, Ie-Ming Shih, Tian-Li Wang
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (7): 1997–2008.
https://doi.org/10.1158/1078-0432.CCR-09-2105
Published: 31 March 2010
View article titled, DNA Copy Numbers Profiles in Affinity-Purified Ovarian Clear Cell Carcinoma
Open the PDF for DNA Copy Numbers Profiles in Affinity-Purified Ovarian Clear Cell Carcinoma in another window
Includes: Supplementary data
Journal Articles

Measurement of Cyclin E Genomic Copy Number and Strand Length in Cell-Free DNA Distinguish Malignant versus Benign Effusions

Ritu Salani, Ben Davidson, Michael Fiegl, Christian Marth, Elisabeth Müller-Holzner, Guenther Gastl, Han-Yao Huang, Jui-Chi Hsiao, Her-Sheng Lin, Tian-Li Wang, Bai-Ling Lin, Ie-Ming Shih
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (19): 5805–5809.
https://doi.org/10.1158/1078-0432.CCR-07-0853
Published: 01 October 2007
View article titled, Measurement of Cyclin E Genomic Copy Number and Strand Length in Cell-Free DNA Distinguish Malignant versus Benign Effusions
Open the PDF for Measurement of Cyclin E Genomic Copy Number and Strand Length in Cell-Free DNA Distinguish Malignant versus Benign Effusions in another window
Journal Articles

Gene Expression Signatures Differentiate Ovarian/Peritoneal Serous Carcinoma from Diffuse Malignant Peritoneal Mesothelioma

Ben Davidson, Zhen Zhang, Lilach Kleinberg, Mei Li, Vivi Ann Flørenes, Tian-Li Wang, Ie-Ming Shih
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (20): 5944–5950.
https://doi.org/10.1158/1078-0432.CCR-06-1059
Published: 24 October 2006
View article titled, Gene Expression Signatures Differentiate Ovarian/Peritoneal Serous Carcinoma from Diffuse Malignant Peritoneal Mesothelioma
Open the PDF for Gene Expression Signatures Differentiate Ovarian/Peritoneal Serous Carcinoma from Diffuse Malignant Peritoneal Mesothelioma in another window
Includes: Supplementary data
Journal Articles

Diffuse Mesothelin Expression Correlates with Prolonged Patient Survival in Ovarian Serous Carcinoma

M. Jim Yen, Chih-Yi Hsu, Tsui-Lien Mao, T-C. Wu, Richard Roden, Tian-Li Wang, Ie-Ming Shih
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (3): 827–831.
https://doi.org/10.1158/1078-0432.CCR-05-1397
Published: 07 February 2006
View article titled, Diffuse Mesothelin Expression Correlates with Prolonged Patient Survival in Ovarian Serous Carcinoma
Open the PDF for Diffuse Mesothelin Expression Correlates with Prolonged Patient Survival in Ovarian Serous Carcinoma in another window
Journal Articles

Characterization of Active Mitogen-Activated Protein Kinase in Ovarian Serous Carcinomas

Chih-Yi Hsu, Robert Bristow, Moon Seok Cha, Brant G. Wang, Chung-Liang Ho, Robert J. Kurman, Tian-Li Wang, Ie-Ming Shih
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (19): 6432–6436.
https://doi.org/10.1158/1078-0432.CCR-04-0893
Published: 08 October 2004
View article titled, Characterization of Active Mitogen-Activated Protein Kinase in Ovarian Serous Carcinomas
Open the PDF for Characterization of Active Mitogen-Activated Protein Kinase in Ovarian Serous Carcinomas in another window